2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005

News and Resources

2006 Releases

11/29/2006 - Opexa Therapeutics to Present at BMO Capital Markets Focus on Healthcare Conference

11/13/2006 - Opexa Reports Third Quarter Financial Results

11/06/2022 - Opexa Begins Dosing Patients in Phase IIb Trial of Tovaxin(TM) for Multiple Sclerosis

10/31/2006 - Opexa Therapeutics to Present at Rodman & Renshaw Eighth Annual Healthcare Conference

10/23/2006 - Opexa Therapeutics to Present at C.E. Unterberg, Towbin Life Sciences Investor Conference

09/18/2006 - Opexa Commences Phase IIb Multiple Sclerosis Study; Reports Positive Phase I/II Data; Provides ...

09/01/2022 - Opexa Shares to Trade on NASDAQ Global Market

08/14/2006 - Opexa Reports Second Quarter Financial Results

06/26/2006 - Scientists at Opexa Therapeutics Generate Human Insulin-Producing Islet Clusters in Culture from ...

06/19/2006 - PharmaFrontiers Changes Name to Opexa Therapeutics; New Ticker Symbol is OPXA

06/16/2006 - PharmaFrontiers Appoints Michael Richman to Board of Directors

06/06/2022 - PharmaFrontiers to Present at Marcus Evans Conference, "Facing Stem Cell Research Challenges"

05/15/2006 - PharmaFrontiers Reports First Quarter 2006 Results

05/03/2022 - PharmaFrontiers Names Lynne Hohlfeld Vice President of Finance

04/17/2006 - PharmaFrontiers Completes $23 Million Financing to Advance Therapeutics; Plans Reverse Stock Split

04/17/2006 - PharmaFrontiers Appoints Gregory Bailey, M.D. and Scott Seaman, CPA, to Board of Directors

04/13/2006 - PharmaFrontiers to Present Data on Adult Human T-Cell Vaccination Technology at the Federation of ...

04/06/2022 - PharmaFrontiers to Present at BIO 2006 Business Forum

03/31/2006 - PharmaFrontiers Reports Year End 2005 Financial Results

03/28/2006 - PharmaFrontiers to Present Data on Adult Human T-Cell and Stem Cell Technologies at the International ...

03/22/2006 - PharmaFrontiers to Present Tovaxin(TM) Research at Consortium of Multiple Sclerosis Centers' Annual

02/23/2006 - PharmaFrontiers Announces Financing Plans

01/17/2006 - PharmaFrontiers Acquires Autologous T Cell Vaccine Rights for Rheumatoid Arthritis